These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8247794)
1. The manufacture and molecular characterization of phosphorothioate deoxynucleotides for use as antisense therapeutics in human clinical trials. Bergot BJ; Foy M; Hansen C; Fearon K; Frediani J; Hirschbein B Nucleic Acids Symp Ser; 1993; (29):57. PubMed ID: 8247794 [No Abstract] [Full Text] [Related]
2. Antisense DNAs as targeted therapeutics for cancer: no longer a dream. Cho-Chung YS Curr Opin Investig Drugs; 2002 Jun; 3(6):934-9. PubMed ID: 12137417 [TBL] [Abstract][Full Text] [Related]
4. Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer. Chi KN; Zoubeidi A; Gleave ME Expert Opin Investig Drugs; 2008 Dec; 17(12):1955-62. PubMed ID: 19012510 [TBL] [Abstract][Full Text] [Related]
5. Targeting Bcl-2 protein expression in solid tumors and hematologic malignancies with antisense oligonucleotides. Tolcher AW Clin Adv Hematol Oncol; 2005 Aug; 3(8):635-42, 662. PubMed ID: 16167050 [TBL] [Abstract][Full Text] [Related]
6. A phase I biological study of MG98, an oligodeoxynucleotide antisense to DNA methyltransferase 1, in patients with high-risk myelodysplasia and acute myeloid leukemia. Klisovic RB; Stock W; Cataland S; Klisovic MI; Liu S; Blum W; Green M; Odenike O; Godley L; Burgt JV; Van Laar E; Cullen M; Macleod AR; Besterman JM; Reid GK; Byrd JC; Marcucci G Clin Cancer Res; 2008 Apr; 14(8):2444-9. PubMed ID: 18413836 [TBL] [Abstract][Full Text] [Related]
7. Deoxyribonucleotides: the unusual chemistry and biochemistry of DNA precursors. Follmann H Chem Soc Rev; 2004 May; 33(4):225-33. PubMed ID: 15103404 [TBL] [Abstract][Full Text] [Related]
13. The clinical experience of antisense therapy to ICAM-1 in Crohn's disease. Yacyshyn B; Bowen-Yacyshyn MB; Shanahan W Curr Opin Mol Ther; 1999 Jun; 1(3):332-5. PubMed ID: 11713798 [TBL] [Abstract][Full Text] [Related]
14. Development of siRNA for therapeutics: efficient synthesis of phosphorothioate RNA utilizing phenylacetyl disulfide (PADS). Ravikumar VT; Andrade M; Carty RL; Dan A; Barone S Bioorg Med Chem Lett; 2006 May; 16(9):2513-7. PubMed ID: 16481168 [TBL] [Abstract][Full Text] [Related]
15. Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates). Stec WJ; Grajkowski A; Koziolkiewicz M; Uznanski B Nucleic Acids Res; 1991 Nov; 19(21):5883-8. PubMed ID: 1945876 [TBL] [Abstract][Full Text] [Related]
16. Technology evaluation: StealthVector (HIV) Enzo. Günzburg W; Mhashilkar AM; Hindi M Curr Opin Mol Ther; 1999 Oct; 1(5):651-7. PubMed ID: 11249672 [TBL] [Abstract][Full Text] [Related]